Analytical Data
-
Gene name
BMP8B
- Application
-
Alternative Names
BMP8-B; OP2; Osteogenic Protein 2
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P55105
-
Expression Region
261-399aa
-
Protein Length
Partial
-
Molecular Weight
28.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BMP8B (Bone Morphogenetic Protein 8B) is a member of the transforming growth factor-beta (TGF-β) superfamily, known for its crucial roles in various biological processes, including bone formation, development, and tissue repair. Research on BMP8B has gained traction due to its potential implications in metabolic regulation and reproductive health. Studies have indicated that BMP8B influences energy balance by modulating thermogenesis and fat metabolism, making it a significant target for obesity and diabetes research. Additionally, BMP8B is involved in the regulation of ovarian follicle development and may play a role in fertility. Recombinant BMP8B protein is thus of particular interest for therapeutic applications, enabling researchers to explore its functions in vivo and in vitro. Its characterization and study could lead to novel strategies for treating metabolic disorders and enhancing reproductive health. As researchers delve into the mechanistic pathways mediated by BMP8B, the recombinant protein serves as a crucial tool in elucidating its role in physiology and potential pathophysiology. Overall, the exploration of BMP8B remains a promising avenue in biomedical research, with the aim of translating these findings into clinical applications for better management of metabolic and reproductive health issues.
